Cro S, Smith CH. Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)': reply from the authors. Br J Dermatol 2022;186:909-910.
PMID: 34878650